Skip to main content
. Author manuscript; available in PMC: 2022 Jan 1.
Published in final edited form as: Alzheimer Dis Assoc Disord. 2021 Jul-Sep;35(3):237–243. doi: 10.1097/WAD.0000000000000439

TABLE 2.

Longitudinal mixed effects models of medication-taking by group

Model 1 Pill-taking Time of Day Model 2 Variability in pill-taking time (minutes) Model 3 Number of days missed
Covariate β Coefficient P-value β Coefficient P-value β Coefficient P-value
Incident MCI vs. Stable cognitively intact −17.46 .83 −10.1 .75 2.02 .28
Monitoring time 0.07 <.001 0.41 .42 0.001 .015
Incident MCI * monitoring time 0.46 <.001 4.0 .003 0.002 .17
Age (years) 4.05 .27 −1.5 .36 −0.11 .26
Female vs. male −45.7 .61 35.1 .19 −0.15 .92

Note. Model 1 metric is in daily units, Model 2 and 3 metrics are aggregated into monthly units.

Longitudinal models for pill-taking time of day are measured in minutes from 5am each day.

Stable cognitively intact (n = 55) vs. Incident MCI (n = 9)